EYES MED
ActiveEYES MED has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.82M and a net result of €271k. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 78% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
95
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79▲+1
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €260k at 30 days acceptable
Liquidity ample (current ratio 6.87 against 3.92 in 2024; short-term debt: 12.1% and cash: 77.8% of total assets), and 13.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
86.7%
Return on assets
8.3%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
29 d late
2023
28 d late
2022
24 d late
2021
29 d late
2020
2 d late
2019
10 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€271k▲ 5.7%
2024 · €256k
2018: €286k
2019: €302k
2020: €225k
2021: €276k
2022: €282k
2023: €276k
2024: €256k
2018 → 2025
Working capital
€2.31M▲ 15.5%
2024 · €2.00M
2018: €1.05M
2019: €1.18M
2020: €1.19M
2021: €1.34M
2022: €1.42M
2023: €1.68M
2024: €2.00M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.94M-€2.02M▲ 3.7%€2.29M▲ 13.7%€2.55M▲ 11.2%€2.82M▲ 10.6%
Operating result€401k-€418k▲ 4.2%€438k▲ 4.9%€415k▼ 5.3%€420k▲ 1.0%
Net result€276k-€282k▲ 2.3%€276k▼ 2.4%€256k▼ 7.0%€271k▲ 5.7%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 1% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.25M
Fixed assets
€553k▼ 12.3%
Current assets
€2.70M▲ 0.7%
Equity and liabilities €3.25M
Equity
€2.82M▲ 10.6%
Debt
€432k▼ 43.2%
The debt ratio falls from 23.0% to 13.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€503k=
2024 · €503k
Cash flow
€354k▲
2024 · €344k
Solvency
86.7%▲
2024 · 77.0%
Current ratio
6.87▲
2024 · 3.92
Quick ratio
6.87▲
2024 · 3.92
Debt / equity
0.15▼
2024 · 0.30
ROE
9.6%▼
2024 · 10.1%
ROA
8.3%▲
2024 · 7.7%
Interest coverage
19.35▲
2024 · 12.81
Debt
€432k▼
2024 · €762k
Debt ≤ 1 year
€393k▼
2024 · €683k
Debt > 1 year
€26k▼
2024 · €61k
Income taxes
€128k▲
2024 · €122k
Staff costs
€59k▲
2024 · €40k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.31M€3.25M▼
Fixed assets21/28€630k€553k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€577k€500k▼
Land and buildings22€479k€441k▼
Plant, machinery and equipment23€187-
Furniture and vehicles24€98k€59k▼
Financial fixed assets28€53k€53k=
Current assets29/58€2.68M€2.70M▲
Amounts receivable within one year40/41€58k€73k▲
Other amounts receivable41€58k€73k▲
Current investments50/53€56€56=
Cash at bank and in hand54/58€2.53M€2.53M▼
Deferred charges and accrued income490/1€92k€98k▲
Equity and liabilities
Total equity and liabilities10/49€3.31M€3.25M▼
Equity10/15€2.55M€2.82M▲
Contributions10/11€41k€41k=
Reserves13€1.90M€2.17M▲
Distributable reserves133€1.90M€2.17M▲
Profit (loss) carried forward14€605k€605k=
Amounts payable17/49€762k€432k▼
Amounts payable after more than one year17€61k€26k▼
Financial debts170/4€61k€26k▼
Amounts payable within one year42/48€683k€393k▼
Current portion of amounts payable after more than one year42€34k€35k▲
Trade debts44€3k-
Suppliers440/4€3k-
Taxes, remuneration and social security45€66k€90k▲
Taxes450/3€65k€89k▲
Remuneration and social security454/9€1k€901▼
Other amounts payable47/48€579k€268k▼
Accrued charges and deferred income492/3€18k€14k▼
Income statement
Code20242025
Remuneration, social security and pensions62€40k€59k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€88k€84k▼
Other operating charges640/8€7k€5k▼
Gross operating margin9900€550k€568k▲
Operating profit (loss)9901€415k€420k▲
Financial income75/76B€2k€5k▲
Recurring financial income75€2k€5k▲
Financial charges65/66B€39k€26k▼
Recurring financial charges65€39k€26k▼
Profit (loss) for the period before taxes9903€378k€399k▲
Income taxes67/77€122k€128k▲
Profit (loss) for the period9904€256k€271k▲
Profit (loss) for the period to be appropriated9905€256k€271k▲
Appropriation of the result
Profit (loss) to be appropriated9906€861k€875k▲
Profit (loss) brought forward from the previous period14P€605k€605k=
Transfer to equity691/2€256k€271k▲
To other reserves6921€256k€271k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 28 days late
2023
24-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 24 days late
2022
31-12
Financial
Equity above €2MEq €2.02M ▲3.7%
5 profitable years in a row build equity to €2.02M.
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 29 days late
2021
02-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 2 days late
2020
31-12
Financial
Weakest financial yearnet €225k ▼25.6%
Net result drops to €225k, the lowest in the series; recovery starts the following year.
10-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 10 days late
2019
31-12
Financial
Highest result since 2018net €302k ▲5.6%
Operating result €474k, net result €302k, both a record.
20-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 20 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
10-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Arlon · 1 establishment unit since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Frassem, rue de la Scierie 126700 ArlonGround area
1,086 m²
Building footprint
167 m²
Volume, LiDAR
826 m³
Parcel 81006C0409/00B000, Wallonia · tallest building 7.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
EYES MED
since 20012.166.099.674
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 81006C0409/00B000 | Wallonia | 1,085 m² | 1 · 167 m² | 7.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Sebamat
BE 0894.129.370
Rumst · Eq €2.82M
DOKTER LIEVEN VERHAMME
BE 0466.581.678
Roeselare · Eq €2.82M
MO ACTIVITIES
BE 0770.711.322
Ukkel · Eq €2.83M
Dr. Ph. Houtmeyers Plastische Heelkunde
BE 0541.660.470
Gent · Eq €2.81M
DRS. ZEYEN-COSEMANS
BE 0866.599.978
Schoten · Eq €2.83M
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 3,826 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-11-2001
Fiscal year end31-12
Activities, NACEBEL
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.